Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosis.
about
Unravelling the metabolic impact of SBS-associated microbial dysbiosis: Insights from the piglet short bowel syndrome model.Nuclear magnetic resonance- and mass spectrometry-based metabolomics to study maleic acid toxicity from repeated dose exposure in rats.Biomarker discovery for drug-induced phospholipidosis: phenylacetylglycine to hippuric acid ratio in urine and plasma as potential markers.
P2860
Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Increased levels of urinary ph ...... drug-induced phospholipidosis.
@en
Increased levels of urinary ph ...... drug-induced phospholipidosis.
@nl
type
label
Increased levels of urinary ph ...... drug-induced phospholipidosis.
@en
Increased levels of urinary ph ...... drug-induced phospholipidosis.
@nl
prefLabel
Increased levels of urinary ph ...... drug-induced phospholipidosis.
@en
Increased levels of urinary ph ...... drug-induced phospholipidosis.
@nl
P2093
P2860
P356
P1476
Increased levels of urinary ph ...... drug-induced phospholipidosis.
@en
P2093
Barbara Lenz
Elke-Astrid Atzpodien
Georg Schmitt
Götz Schlotterbeck
Holger Fischer
Laura Suter
Lucette Doessegger
Miklos Csato
Stefan Evers
P2860
P304
P356
10.1177/2042098613479393
P577
2013-06-01T00:00:00Z